MORONI, GABRIELLA
 Distribuzione geografica
Continente #
NA - Nord America 2.365
EU - Europa 1.125
AS - Asia 1.120
SA - Sud America 263
AF - Africa 32
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.913
Nazione #
US - Stati Uniti d'America 2.301
SG - Singapore 485
CN - Cina 277
BR - Brasile 200
DE - Germania 199
IT - Italia 199
RU - Federazione Russa 172
HK - Hong Kong 142
IE - Irlanda 132
SE - Svezia 97
VN - Vietnam 79
AT - Austria 78
GB - Regno Unito 59
FR - Francia 42
IN - India 32
JP - Giappone 31
CA - Canada 29
MX - Messico 25
UA - Ucraina 25
AR - Argentina 22
ES - Italia 20
FI - Finlandia 19
DK - Danimarca 18
GR - Grecia 15
TR - Turchia 14
ZA - Sudafrica 14
BD - Bangladesh 11
PL - Polonia 11
CO - Colombia 10
IQ - Iraq 9
NL - Olanda 9
PT - Portogallo 9
EC - Ecuador 8
ID - Indonesia 8
EG - Egitto 7
AU - Australia 6
PE - Perù 6
SA - Arabia Saudita 5
UY - Uruguay 5
UZ - Uzbekistan 5
VE - Venezuela 5
KR - Corea 4
LT - Lituania 4
MA - Marocco 4
NO - Norvegia 4
PK - Pakistan 4
AZ - Azerbaigian 3
CL - Cile 3
CZ - Repubblica Ceca 3
MY - Malesia 3
PA - Panama 3
PY - Paraguay 3
TN - Tunisia 3
AL - Albania 2
BG - Bulgaria 2
JM - Giamaica 2
JO - Giordania 2
NG - Nigeria 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
BH - Bahrain 1
CH - Svizzera 1
CR - Costa Rica 1
GA - Gabon 1
HN - Honduras 1
IR - Iran 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
SC - Seychelles 1
SR - Suriname 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.913
Città #
Ann Arbor 520
Singapore 328
Ashburn 265
Fairfield 154
Frankfurt am Main 145
Hong Kong 140
Dublin 131
Chandler 126
Wilmington 108
New York 71
Vienna 70
Woodbridge 67
Houston 64
Seattle 63
Cambridge 58
Beijing 56
Dallas 54
Los Angeles 52
Santa Clara 50
Milan 44
Dearborn 41
Princeton 40
Shanghai 27
Munich 25
Guangzhou 23
Nanjing 23
São Paulo 21
Chicago 19
Hanoi 19
Altamura 18
Buffalo 18
Lawrence 17
Ho Chi Minh City 16
San Diego 15
Dong Ket 13
London 13
Moscow 12
The Dalles 11
Athens 10
Hefei 10
Jacksonville 10
Tokyo 10
Brooklyn 9
Turku 9
Warsaw 9
Dundee 8
Lissone 8
Mexico City 8
Buenos Aires 7
Curitiba 7
Denver 7
Helsinki 7
Jakarta 7
Johannesburg 7
Montreal 7
Rome 7
Andover 6
Barcelona 6
Campinas 6
Hangzhou 6
Olbia 6
Orem 6
Ottawa 6
Phoenix 6
Porto Alegre 6
Rio de Janeiro 6
Ankara 5
Chennai 5
Columbus 5
Edmonton 5
Nuremberg 5
Poplar 5
Saint Louis 5
San Jose 5
Santiago de Cali 5
Toronto 5
Arlington 4
Atlanta 4
Belo Horizonte 4
Calgary 4
Changsha 4
Delhi 4
Genova 4
Hải Dương 4
Manchester 4
Melbourne 4
Mumbai 4
Nanchang 4
New Delhi 4
Oslo 4
Paris 4
Philadelphia 4
Sacramento 4
Salt Lake City 4
Salvador 4
Seoul 4
Shenyang 4
Tashkent 4
Venice 4
Vila Real 4
Totale 3.290
Nome #
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 600
Kidney Involvement 324
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 308
Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient) 304
Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients 300
Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis 283
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 271
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 249
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 233
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 230
FP165 Slowly progressive anca-associated glomerulonephritis: a multicentre study 205
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study 199
RITUXIMAB AS MAINTENANCE THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS 195
Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: clinico-pathological characterization and outcome 188
Milder clinical presentation of lupus nephritis and improved renal survival during the last 50 years: a multicentric study 181
CLINICAL FEATURES AND RENAL PROGNOSIS IN LUPUS NEPHRITIS PATIENTS UNDERGOING A REPEATED BIOPSY: RESULTS OF 103 RE-BIOPSIES IN 438 PATIENTS 180
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 172
Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood 165
Evidence for charge-based mimicry in anti dsDNA antibody generation 163
P0346THE EFFECTS OF RITUXIMAB MAINTENANCE THERAPY ON LUPUS NEPHRITIS 143
Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients 142
Totale 5.035
Categoria #
all - tutte 16.776
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.776


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021368 0 0 0 0 0 0 81 70 51 50 45 71
2021/2022360 41 77 41 30 16 28 14 13 12 20 28 40
2022/2023561 39 175 81 45 22 83 14 26 48 5 13 10
2023/2024436 14 12 23 31 51 115 68 10 42 12 8 50
2024/20251.098 50 107 105 43 83 47 101 19 134 178 105 126
2025/20261.262 283 80 178 281 298 131 11 0 0 0 0 0
Totale 5.035